Brian Powl

Insider Reports History

Entity
Individual
Location
C/O Fate Therapeutics, Inc., 12278 Scripps Summit Drive, San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Brian Powl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Powl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FATE THERAPEUTICS INC Chief Commercial Officer Common Stock 41.1K $180K $4.37 Jul 5, 2023 Direct
Kura Oncology, Inc. Chief Commercial Officer Common Stock 15K $173K $11.50 Jan 2, 2024 Direct
Kura Oncology, Inc. Chief Commercial Officer Option to purchase common stock 30K Jan 2, 2024 Direct

Insider Reports Filed by Brian Powl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KURA Kura Oncology, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Commercial Officer
KURA Kura Oncology, Inc. Aug 14, 2023 1 $0 4 Aug 16, 2023 Chief Commercial Officer
KURA Kura Oncology, Inc. Aug 14, 2023 0 $0 3 Aug 16, 2023 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Jul 5, 2023 1 -$18.8K 4 Jul 6, 2023 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Feb 6, 2023 1 $0 4 Feb 7, 2023 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Jun 27, 2022 2 $0 4 Jun 29, 2022 Chief Commercial Officer
FATE FATE THERAPEUTICS INC Jun 27, 2022 0 $0 3 Jun 29, 2022 Chief Commercial Officer